Antibody antagonists of interleukin-13 receptor alpha 1

Details for Australian Patent Application No. 2007311002 (hide)

International Classifications

Event Publications

11 June 2009 PCT application entered the National Phase

PCT publication WO2008/049098 Priority application(s): WO2008/049098

18 June 2009 Amendment Made

The nature of the amendment is: Amend the invention title to read Antibody antagonists of interleukin-13 receptor alpha 1

28 January 2010 Alteration of Name

The name of the applicant has been altered to CSL Limited; Merck Sharp & Dohme Corp.

16 September 2010 Assignment before Grant

Merck Sharp & Dohme Corp. The application has been assigned to CSL Limited

12 January 2012 Application Accepted

Published as AU-B-2007311002

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.